
Commure
Commure develops AI software for the healthcare industry, including tools for clinical documentation, revenue cycle management, and patient engagement.
Secondary Market Price
How Commure Measures Up
To help you manage your Commure equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
Series E
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Commure's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Commure Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Commure's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.

Powerful tools to earn more from your equity

Company Description
Commure is a technology company that develops AI-powered software for the healthcare industry. Its product suite includes Scribe, a mobile application for automatic clinical documentation and workflow integration; Revenue Cycle Management (RCM), a system for managing patient payments and analyzing data; and Engage, a tool for patient activation and monitoring. Founded in 2017, the company is headquartered in Mountain View, California. Commure has raised a total of $542.3 million in funding and has approximately 1,491 employees.
Public information regarding recent announcements, future plans, or a product roadmap for the company is not available in the provided materials.
- General Catalyst
- Sequoia Capital
- Y Combinator
- Lux Capital
- Human Capital
- 8VC
- Greenoaks Capital
- Elad Gil
- Co-Founder, Hemant Taneja
- Co-Founder, Eugene Kuznetsov
- Co-Founder, Diede van Lamoen
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Commure worth joining?
Deciding to join a startup like Commure involves evaluating its potential growth, culture, and the value of its compensation package. To understand the potential financial outcome of your equity, you can use platforms like Prospect, which models the future value of startup shares.
What should I do with my Commure stock?
Managing startup stock involves creating a strategy for when to exercise options and sell shares to optimize your financial outcome and minimize taxes. Prospect can help you build a personalized plan by modeling tax implications and projecting your equity's future value.
Can you sell Commure stock?
As Commure is a private company, you can typically only sell stock during specific events like a tender offer or on a secondary market. Tools from Prospect can help you determine how much to sell and which shares are most tax-optimal to offload during these opportunities.
How can I find the value of my Commure stock?
The value of private stock isn't publicly listed and is formally assessed through a 409A valuation, which may not reflect its true market potential. You can get a better projection by using Prospect's predictive models, which analyze data like funding rounds and market trends to forecast your equity's value.
What is Commure's equity worth?
The precise worth of Commure's equity is difficult to determine as it is a private company and its value fluctuates based on performance and market conditions. To get a data-driven estimate, you can use a platform like Prospect, which uses proprietary models to project the future value of private company shares.
What is Commure's stock ticker symbol?
Commure is a privately held company, so it is not traded on a public stock exchange. Therefore, it does not have a stock ticker symbol.
Can I buy or sell Commure stock?
As an employee, you may be able to sell your shares during limited windows like tender offers, while buying shares is typically restricted to accredited investors in private funding rounds. If you are an employee considering a sale, Prospect offers tools to help you navigate tender offers and optimize your selling strategy for taxes.
What is the criteria to buy or invest in Commure stock?
Investing in a private company like Commure is generally limited to accredited investors, as defined by financial regulators. This typically includes individuals with a high net worth or income, or those with specific professional certifications.

